64 related articles for article (PubMed ID: 22800753)
21. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
22. [Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].
Yagn WB; Cai F; Cheng CT; Cao G; Qin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):728-31. PubMed ID: 19180924
[TBL] [Abstract][Full Text] [Related]
23. Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.
Zhong N; Cui Y; Zhou X; Li T; Han J
Tumour Biol; 2015 Feb; 36(2):1221-31. PubMed ID: 25344214
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
26. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
27. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.
Hoshi H; Sawada T; Uchida M; Saito H; Iijima H; Toda-Agetsuma M; Wada T; Yamazoe S; Tanaka H; Kimura K; Kakehashi A; Wei M; Hirakawa K; Wanibuchi H
Int J Oncol; 2011 Mar; 38(3):619-27. PubMed ID: 21249315
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
30. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
[TBL] [Abstract][Full Text] [Related]
32. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
34. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer.
Liu A; Chen H; Wei W; Ye S; Liao W; Gong J; Jiang Z; Wang L; Lin S
Oncol Rep; 2011 Jul; 26(1):81-9. PubMed ID: 21491088
[TBL] [Abstract][Full Text] [Related]
36. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
[TBL] [Abstract][Full Text] [Related]
37. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
38. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
[TBL] [Abstract][Full Text] [Related]
39. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2.
Gonzalez DE; Covitz KM; Sadée W; Mrsny RJ
Cancer Res; 1998 Feb; 58(3):519-25. PubMed ID: 9458100
[TBL] [Abstract][Full Text] [Related]
40. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
